Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Efficacy of erenumab in chronic migraine patients with and without ictal allodynia.

Efficacy of erenumab in chronic migraine patients with and without ictal allodynia. Cephalalgia. 2021 10; 41(11-12):1152-1160.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.